supplementary information key intermediate of ticagrelor · supplementary information highly...

12
Supplementary Information Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: Key intermediate of Ticagrelor Manpreet Singh 1 , Hare Krishnen 1 , Goverdhan Gilla 1 , Kavitha Charugondla 1 , Karen Holt- Tiffin 2 and Rakeshwar Bandichhor 1* *Corresponding author. Telephone: +91 40 44346430 Fax: +91 40 44346164 E-mail: [email protected] Electronic Supplementary Material (ESI) for RSC Advances. This journal is © The Royal Society of Chemistry 2016

Upload: others

Post on 14-Mar-2020

20 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Supplementary Information Key intermediate of Ticagrelor · Supplementary Information Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: Key intermediate

Supplementary Information

Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: Key intermediate of Ticagrelor

Manpreet Singh1, Hare Krishnen1, Goverdhan Gilla1, Kavitha Charugondla1, Karen Holt-Tiffin2 and Rakeshwar Bandichhor1*

*Corresponding author. Telephone: +91 40 44346430

Fax: +91 40 44346164

E-mail: [email protected]

Electronic Supplementary Material (ESI) for RSC Advances.This journal is © The Royal Society of Chemistry 2016

Page 2: Supplementary Information Key intermediate of Ticagrelor · Supplementary Information Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: Key intermediate

2

Table of contents

Scheme 1 ................................................................................................................................................3

1. HPLC Methods ...............................................................................................................................4

a) Purity by HPLC: Standard ..........................................................................................................4

b) Purity by HPLC: 1-(3,4-difluorophenyl)-3-nitropropan-1-ol......................................................5

c) Chiral HPLC: Standards (1) (2) and (6)......................................................................................6

d) Chiral HPLC: Preparative batch sample .....................................................................................7

2. NMR spectra...................................................................................................................................8

a) 1H-NMR spectra: 1-(3,4-Difluorophenyl)-3-nitropropan-1-one .................................................8

b) 13H-NMR spectra: 1-(3,4-Difluorophenyl)-3-nitropropan-1-one ................................................9

c) 1H-NMR spectra: 1-(3,4-difluorophenyl)-3-nitropropan-1-ol...................................................10

3. Mass Spectrum: 1-(3,4-difluorophenyl)-3-nitropropan-1-ol.........................................................11

4. IR Spectrum: (S)-1-(3,4-difluorophenyl)-3-nitropropan-1-ol .......................................................12

Page 3: Supplementary Information Key intermediate of Ticagrelor · Supplementary Information Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: Key intermediate

3

Scheme 1

FF

O

FF

NO2

FF

NH2Zn dust

(R)-(+)-2-Methyl-CBS-oxazaborolidine

F

F

HN

N

NNNNO

HO

HO OH

S CH3

NO2F

F

OH

NO2

PPh3

DEAD

chemocatalysis

biocatalysis

1 2

34

Ticagrelor, 5

C. parapsilosis, 85%, 98% ee

75%, 94% eereported F

F

OH

NO2

+

6

Page 4: Supplementary Information Key intermediate of Ticagrelor · Supplementary Information Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: Key intermediate

4

1. HPLC Methods

a) Purity by HPLC: Standard

Determined by HPLC using Zorbex Eclipse Plus C-18 at 210 nm. Mobile phase consisted of

A: 0.02 M KH2PO4 buffer pH 3.0 and B: ACN:H2O (90:10 v/v).

Figure S1: HPLC spectrum of standard substrate (1) and product (2).

1- RT 8.222- RT 7.71

Page 5: Supplementary Information Key intermediate of Ticagrelor · Supplementary Information Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: Key intermediate

5

b) Purity by HPLC: 1-(3,4-difluorophenyl)-3-nitropropan-1-ol

Determined by HPLC using Zorbex Eclipse Plus C-18 at 210 nm. Mobile phase consisted of

A: 0.02 M KH2PO4 buffer pH 3.0 and B: ACN:H2O (90:10 v/v).

Figure S2: HPLC spectrum of preparative scale batch 1-(3,4-difluorophenyl)-3-nitropropan-1-ol (2).

2-RT 7.53

Page 6: Supplementary Information Key intermediate of Ticagrelor · Supplementary Information Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: Key intermediate

6

c) Chiral HPLC: Standards (1) (2) and (6)

Determined by using chiral HPLC column Chiralcel OD-H at 210 nm. Mobile phase

consisted of Hexane/iPrOH/TFA (92:7.9:0.1).

Figure S3: Chiral HPLC spectrum of standard (1) (2) and (6).

1-RT 27.62-RT 15.156-RT 13.58

Page 7: Supplementary Information Key intermediate of Ticagrelor · Supplementary Information Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: Key intermediate

7

d) Chiral HPLC: Preparative batch sample

Determined by using chiral HPLC column Chiralcel OD-H at 210 nm. Mobile phase

consisted of Hexane/iPrOH/TFA (92:7.9:0.1).

Figure S4: Chiral HPLC spectrum of preparative batch showing (1), (2) and (6)

2

6

Page 8: Supplementary Information Key intermediate of Ticagrelor · Supplementary Information Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: Key intermediate

8

2. NMR spectra

a) 1H-NMR spectra: 1-(3,4-Difluorophenyl)-3-nitropropan-1-one

Figure S5: 1H NMR spectrum of 1-(3,4-difluorophenyl)-3-nitropropan-1-one in CDCl3.

FF NO2

O1

2

3 4

5

1, 2, 3

45

Page 9: Supplementary Information Key intermediate of Ticagrelor · Supplementary Information Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: Key intermediate

9

b) 13H-NMR spectra: 1-(3,4-Difluorophenyl)-3-nitropropan-1-one

Figure S6: 13C NMR spectrum of (S)-1-(3,4-difluorophenyl)-3-nitropropan-1-ol in CDCl3.

FF NO2

O

1 2

34

569

78

1

2

3

4

5

6, 9

7, 8

Page 10: Supplementary Information Key intermediate of Ticagrelor · Supplementary Information Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: Key intermediate

10

c) 1H-NMR spectra: 1-(3,4-difluorophenyl)-3-nitropropan-1-ol

Figure S7: 1H NMR spectrum of (S)-1-(3,4-difluorophenyl)-3-nitropropan-1-ol in CDCl3.

F

F

O2N

OH

12

3

4

5

6

7

1, 2, 3, 4

5, 6 7

Page 11: Supplementary Information Key intermediate of Ticagrelor · Supplementary Information Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: Key intermediate

11

3. Mass Spectrum: 1-(3,4-difluorophenyl)-3-nitropropan-1-ol

Figure S8: Mass (M-H) spectrum of (S)-1-(3,4-difluorophenyl)-3-nitropropan-1-ol.

Page 12: Supplementary Information Key intermediate of Ticagrelor · Supplementary Information Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: Key intermediate

12

4. IR Spectrum: (S)-1-(3,4-difluorophenyl)-3-nitropropan-1-ol

Figure S9: IR spectrum of (S)-1-(3,4-difluorophenyl)-3-nitropropan-1-ol.